268 related articles for article (PubMed ID: 25799372)
1. Fibrillar amyloid plaque formation precedes microglial activation.
Jung CK; Keppler K; Steinbach S; Blazquez-Llorca L; Herms J
PLoS One; 2015; 10(3):e0119768. PubMed ID: 25799372
[TBL] [Abstract][Full Text] [Related]
2. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
3. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
4. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
[TBL] [Abstract][Full Text] [Related]
5. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
6. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
7. Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy SA; Yang F; Irrizarry M; Hyman B; Saido TC; Hsiao K; Cole GM
Am J Pathol; 1998 Jan; 152(1):307-17. PubMed ID: 9422548
[TBL] [Abstract][Full Text] [Related]
8. Determination of spatial and temporal distribution of microglia by 230nm-high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer's disease.
Scheffler K; Stenzel J; Krohn M; Lange C; Hofrichter J; Schumacher T; Brüning T; Plath AS; Walker L; Pahnke J
Curr Alzheimer Res; 2011 Nov; 8(7):781-8. PubMed ID: 21244350
[TBL] [Abstract][Full Text] [Related]
9. NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.
Manocha GD; Ghatak A; Puig KL; Kraner SD; Norris CM; Combs CK
J Alzheimers Dis; 2017; 58(3):775-787. PubMed ID: 28505967
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
11. Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.
Solberg NO; Chamberlin R; Vigil JR; Deck LM; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Bisoffi M; Severns V; Vander Jagt DL; Sillerud LO
J Alzheimers Dis; 2014; 40(1):191-212. PubMed ID: 24413613
[TBL] [Abstract][Full Text] [Related]
12. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.
Zhao R; Hu W; Tsai J; Li W; Gan WB
Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182
[TBL] [Abstract][Full Text] [Related]
13. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
[TBL] [Abstract][Full Text] [Related]
14. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
15. A modified formulation of Huanglian-Jie-Du-Tang reduces memory impairments and β-amyloid plaques in a triple transgenic mouse model of Alzheimer's disease.
Durairajan SSK; Iyaswamy A; Shetty SG; Kammella AK; Malampati S; Shang W; Yang C; Song J; Chung S; Huang J; Ilango K; Han QB; Li M
Sci Rep; 2017 Jul; 7(1):6238. PubMed ID: 28740171
[TBL] [Abstract][Full Text] [Related]
16. Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice.
Wegiel J; Imaki H; Wang KC; Wegiel J; Wronska A; Osuchowski M; Rubenstein R
Acta Neuropathol; 2003 Apr; 105(4):393-402. PubMed ID: 12624793
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
[TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
[TBL] [Abstract][Full Text] [Related]
19. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
20. The increased density of p38 mitogen-activated protein kinase-immunoreactive microglia in the sensorimotor cortex of aged TgCRND8 mice is associated predominantly with smaller dense-core amyloid plaques.
Chlan-Fourney J; Zhao T; Walz W; Mousseau DD
Eur J Neurosci; 2011 Apr; 33(8):1433-44. PubMed ID: 21323766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
